Bank of New York Mellon’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,479
| Closed | -$3.99K | – | 4441 |
|
|
2022
Q4 | $3.99K | Hold |
1,479
| – | – | ﹤0.01% | 4451 |
|
|
2022
Q3 | $6K | Hold |
1,479
| – | – | ﹤0.01% | 4526 |
|
|
2022
Q2 | $10K | Hold |
1,479
| – | – | ﹤0.01% | 4546 |
|
|
2022
Q1 | $18K | Hold |
1,479
| – | – | ﹤0.01% | 4622 |
|
|
2021
Q4 | $27K | Hold |
1,479
| – | – | ﹤0.01% | 4565 |
|
|
2021
Q3 | $37K | Hold |
1,479
| – | – | ﹤0.01% | 4465 |
|
|
2021
Q2 | $94K | Sell |
1,479
-6,464
| -81% | -$411K | ﹤0.01% | 4222 |
|
|
2021
Q1 | $979K | Buy |
7,943
+310
| +4% | +$38.2K | ﹤0.01% | 3339 |
|
|
2020
Q4 | $869K | Buy |
7,633
+1,690
| +28% | +$192K | ﹤0.01% | 3334 |
|
|
2020
Q3 | $710K | Buy |
5,943
+1,013
| +21% | +$121K | ﹤0.01% | 3312 |
|
|
2020
Q2 | $614K | Buy |
4,930
+2,499
| +103% | +$311K | ﹤0.01% | 3371 |
|
|
2020
Q1 | $469K | Buy |
2,431
+1,470
| +153% | +$284K | ﹤0.01% | 3399 |
|
|
2019
Q4 | $320K | Hold |
961
| – | – | ﹤0.01% | 3775 |
|
|
2019
Q3 | $309K | Buy |
961
+242
| +34% | +$77.8K | ﹤0.01% | 3767 |
|
|
2019
Q2 | $311K | Buy |
719
+174
| +32% | +$75.3K | ﹤0.01% | 3791 |
|
|
2019
Q1 | $308K | Buy |
545
+8
| +1% | +$4.52K | ﹤0.01% | 3732 |
|
|
2018
Q4 | $159K | Buy |
537
+181
| +51% | +$53.6K | ﹤0.01% | 3891 |
|
|
2018
Q3 | $252K | Buy |
356
+65
| +22% | +$46K | ﹤0.01% | 3864 |
|
|
2018
Q2 | $170K | Buy |
291
+39
| +15% | +$22.8K | ﹤0.01% | 3929 |
|
|
2018
Q1 | $682K | Buy |
+252
| New | +$682K | ﹤0.01% | 3419 |
|